We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

202 hedge funds and large institutions have $2.28B invested in Ariad Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 63 increasing their positions, 62 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more capital invested

Capital invested by funds: $1.04B → $2.28B (+$1.25B)

69% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 29

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

11% more funds holding

Funds holding: 182 → 202 (+20)

2% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 62

26% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $39.1M

Holders
202
Holders Change
+20
Holders Change %
+10.99%
% of All Funds
5.39%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.21%
New
49
Increased
63
Reduced
62
Closed
29
Calls
$29.1M
Puts
$39.1M
Net Calls
-$10M
Net Calls Change
-$11.6M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$172M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$91.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$59.7M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$25.5M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$82.3M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$45.9M
3
CCM
Camber Capital Management
Massachusetts
-$29.6M
4
ECP
Elk Creek Partners
Colorado
-$11.7M
5
JIM
Jupiter Investment Management
United Kingdom
-$9.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
176
Cutler Group
California
$31K -$53.2K -5,300 -70%
EWM
177
Edge Wealth Management
New York
$27K -$10K -1,000 -33%
BJ
178
BlackRock Japan
Japan
$23K +$4.31K +429 +33%
LAM
179
Lebenthal Asset Management
New York
$23K +$17.2K +1,710 New
Fifth Third Bancorp
180
Fifth Third Bancorp
Ohio
$21K – – –
MFW
181
Mosaic Family Wealth
Missouri
$20K – – –
MCM
182
Manchester Capital Management
Vermont
$14K – – –
QCG
183
Quadrant Capital Group
Ohio
$12K – – –
FNBT
184
FineMark National Bank & Trust
Florida
$11K +$8.03K +800 New
GXMC
185
Global X Management Company
New York
$9K – – –
TCOV
186
Trust Company of Vermont
Vermont
$9K – – –
WA
187
WFG Advisors
Texas
$9K +$6.53K +650 New
ACH
188
ArrowMark Colorado Holdings
Colorado
$9K +$6.64K +661 New
TCIM
189
TIAA CREF Investment Management
New York
$7.48K -$305K -30,378 -5%
FANJ
190
Financial Architects (New Jersey)
New Jersey
$7K – – –
TRCT
191
Tower Research Capital (TRC)
New York
$6K +$4.62K +460 New
DADC
192
D.A. Davidson & Co
Montana
$5K – – –
ADL
193
Asset Dedication LLC
California
$5K +$3.41K +340 New
HR
194
Howe & Rusling
New York
$5K +$3.56K +355 New
RFA
195
Reilly Financial Advisors
California
$3K – – –
TDC
196
Thompson Davis & Co
Virginia
$3K +$2.51K +250 New
WAM
197
Wealthspire Advisors (Maryland)
Maryland
$2K -$271 -27 -16%
AA
198
AlphaMark Advisors
Kentucky
$2K – – –
VOYA Investment Management
199
VOYA Investment Management
Georgia
$1.02K – – –
HMS
200
Hanseatic Management Services
New Mexico
$1K -$100 -10 -10%
6 7
8
9 10

ARIA Hedge Fund Activity: Q3 2016 in Review

202 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2016, worth a combined $2.28B — up 120% from $1.04B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ARIA positions and 29 closed out — a net gain of 20 holders — while 63 added to existing stakes and 62 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $172M. The largest seller was Putnam Investments, cutting an estimated $82.3M.

  • 202 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2016, up from 182 in Q2 2016.
  • Funds reported $2.28B of Ariad Pharmaceuticals Inc stock for Q3 2016, up 120% quarter-over-quarter.
  • 49 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2016 and 29 closed out, a net change of +20 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2016 was Wellington Management Group, an estimated $172M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2016 was Putnam Investments, an estimated $82.3M sold.

Based on aggregated 13F filings for Q3 2016.